Neuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 30 2020 - 4:05PM
Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical
technology company focused on designing, developing and marketing
products that improve the quality of life for patients who suffer
from psychiatric disorders, today announced that Keith Sullivan,
President and Chief Executive Officer, and Steve Furlong, Chief
Financial Officer, will participate in the Piper Sandler 32nd
Annual Virtual Healthcare Conference on Wednesday, December 2,
2020. A pre-recorded webcast of the conference presentation will be
available online at the investor relations page of the Company’s
website at
ir.neuronetics.com. A replay of the
webcast will be archived on the website for approximately 90
days.
About NeuroneticsNeuronetics, Inc. is a
commercial-stage medical technology company focused on designing,
developing, and marketing products that improve the quality of life
for patients who suffer from psychiatric disorders. Its commercial
product, the NeuroStar® Advanced Therapy System, is a non-invasive
and non-systemic office-based treatment that uses transcranial
magnetic stimulation, or TMS, to create a pulsed, MRI-strength
magnetic field that induces electrical currents designed to
stimulate specific areas of the brain associated with mood. The
system is cleared by the United States Food and Drug
Administration, or FDA, for the treatment of major depressive
disorder in adult patients who have failed to achieve satisfactory
improvement from prior antidepressant medication in the current
episode. NeuroStar is also available in other parts of the world,
including Japan, where it is listed under Japan’s national health
insurance. Additional information can be found at
www.neuronetics.com.Investor Contact:Mark R.
KlausnerWestwicke
Partners443-213-0501
ir@neuronetics.comMedia
Contact:Meagan DominicVault
Communications610-455-2779
mdominick@vaultcommunications.com
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Apr 2023 to Apr 2024